-
-
Pharma & Human Health -
Finance -
Finance -
Editor's Choice
Editor’s Choice
Editor's Choice
Lallemand’s New R&D Laboratories: An Exclusive Interview with Sylvie Binda, VP of R&D
Following the announcement of Lallemand’s new R&D laboratories in France, Microbiome Times caught up with Sylvie Binda, VP of R&D to discuss the company’s goals and objectives. Can you elaborate on how the new laboratories […]
Editor's Choice
Health Canada Licenses Probiotical’s PROBIAL DERM® for Eczema and Atopic Dermatitis Claims
Eczema and Atopic Dermatitis (AD) is thought to affect as many as 10% of adults worldwide and represents a debilitating condition for many.1 It can result in a lower quality of life, and reports link […]
Editor's Choice
Precision metagenomics: a rapid solution for identifying and characterizing microbial agents of infectious disease.
Next-generation sequencing (NGS) represents an innovative and versatile technology for microbial identification and characterization. NGS offers flexibility to scale methods based on the experimental interest. Widely available NGS methods include amplicon sequencing, hybrid capture, whole-genome […]
In Case you Missed it:
Pharma & Human Health
Quadram Institute announces Professor Daniel Figeys as new Director and Chief Executive
Professor Figeys is the founding Director of the School of Pharmaceutical Sciences and of the Ottawa Institute of Systems Biology, Faculty of Medicine, at the University of Ottawa in Canada. His research focuses on developing […]
Pharma & Human Health
EnteroBiotix Announces Positive Ph1b Clinical Results of EBX-102 in Liver Cirrhosis
EnteroBiotix Limited (‘EnteroBiotix’ or the ‘Company’), a clinical-stage biotechnology company focussed on developing best-in-class full-spectrum microbiome therapeutics, today announced positive results from its Phase 1b IMPuLCE study evaluating EBX-102 in patients with liver cirrhosis. EnteroBiotix’s […]
Pharma & Human Health
Updates from MaaT Pharma’s Early Access Program Demonstrate Prolonged Long-Term Survival in Patients Receiving MaaT013
MaaT Pharma (EURONEXT: MAAT – the “Company”), a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem TherapiesTM (MET) dedicated to enhancing survival for patients with cancer through immune modulation, announced updated […]
Pharma & Human Health
Researchers hope to develop novel drugs for gastrointestinal disorders by fermenting feces
In a new study, researchers at the University of Copenhagen have been cultivating ‘good viruses’ from feces. The goal is to replace fecal capsules now being used in so-called fecal transplants. Their new technique has […]
Pharma & Human Health
Cerillo Introduces First Standardized Co-Culture System Revolutionizing Microbial Interaction and Isolation Studies
Cerillo, a leader in cellular analytics, announces the release of Duet, the first standardized co-culture system that allows researchers to explore microbial and cellular interactions in real time. Designed to address challenges in microbial research, Duet offers a […]
Editor's Choice
Health Canada Licenses Probiotical’s PROBIAL DERM® for Eczema and Atopic Dermatitis Claims
Eczema and Atopic Dermatitis (AD) is thought to affect as many as 10% of adults worldwide and represents a debilitating condition for many.1 It can result in a lower quality of life, and reports link […]
Editor's Choice
Precision metagenomics: a rapid solution for identifying and characterizing microbial agents of infectious disease.
Next-generation sequencing (NGS) represents an innovative and versatile technology for microbial identification and characterization. NGS offers flexibility to scale methods based on the experimental interest. Widely available NGS methods include amplicon sequencing, hybrid capture, whole-genome […]
Pharma & Human Health
Sequential Launches Industry-First Microbiome Target Panels for Skin Conditions
Sequential is excited to announce the launch of the industry’s first-ever Targeted Skin Condition Panels through the lens of the Microbiome, designed to address major skin concerns such as acne, rosacea, atopic dermatitis, malodor, and […]
